King Philippe - Filip of Belgium arrives for a royal visit to Pfizer-BioNTech s corona vaccine production site in Puurs, Tuesday 30 March 2021. The pharmaceutical group Pfizer completes its mRNA vaccine at this site before shipping the vials to 176 countries around the world. For the first time, the king will receive an explanation of the SKID machine, which encapsulates the active ingredient of the mRNA vaccine with the necessary lipids for effective operation. The king will also talk to management and employees about the enormous efforts that are being made from Puurs to provide many world regions, but also our country, with a preventive means against the corona virus. POOLxSTEPHANIExLECOCQ 2684036
Choose your license
Rights Managed:
One-time editorial use in an online article, social media channels, internal presentation, website, newsletter, or blog.
One-time editorial use in a book, newspaper or magazine (excluding cover page), external presentation. Limited to 5,000 circulation. This includes the rights available in the Standard license.
Media Info
Credit: Belga
Media ID:
Recording Date: Mar 30, 2021
Media Size: 3,126×2,084 Pixels
King Philippe - Filip of Belgium arrives for a royal visit to Pfizer-BioNTech s corona vaccine production site in Puurs, Tuesday 30 March 2021. The pharmaceutical group Pfizer completes its mRNA vaccine at this site before shipping the vials to 176 countries around the world. For the first time, the king will receive an explanation of the SKID machine, which encapsulates the active ingredient of the mRNA vaccine with the necessary lipids for effective operation. The king will also talk to management and employees about the enormous efforts that are being made from Puurs to provide many world regions, but also our country, with a preventive means against the corona virus. POOLxSTEPHANIExLECOCQ 2684036
Restrictions: This image can not be published in Belgium, France, Netherlands, .
Release Info: Do I need a release?
Captions may have been translated or enriched by an AI system.
For more information about AI-assisted captions, see AI-assisted captions.
Need a custom license?
If your intended use isn't covered by the available options (such as non-editorial purposes or specific distribution needs), contact us. Our team will be happy to provide a tailored offer based on your requirements.